Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum Nov 16, 2020 12:00PM
Meridian Bioscience to Participate in Canaccord Genuity Virtual MedTech & Diagnostics Forum Nov 16, 2020 12:00PM
Canaccord Genuity Downgrades Meridian Biosciences (VIVO) to Sell Apr 3, 2019 07:25AM
Meridian Biosciences (VIVO) PT Raised to $15 at Canaccord Genuity May 2, 2017 10:37AM
Canaccord Genuity Remains Sidelined Following Meridian Bioscience's (VIVO) Announced Magellan Diagnostics Acquisition Mar 28, 2016 10:17AM


Jul 27, 2015 09:18AM Canaccord Genuity Cuts Price Target on Meridian Bioscience (VIVO) Following In-Line Quarter Results
Jan 2, 2015 10:49AM Notable Analyst Rating Changes 1/2: (LH) (BBBY) (FNF) Upgraded; (FTI) (SWIR) (XRAY) Downgraded
Jul 27, 2012 01:43PM UPDATE: Canaccord Genuity Downgrades Meridian Biosciences (VIVO) to Hold; Changing Investment Thesis
Jul 12, 2012 01:35PM Canaccord Genuity Maintains a 'Buy' on Meridian Biosciences (VIVO); Q3 Preview: Performing Well Despite Hurdles